Lunai Bioworks Inc.
corporate_fare Company Profile
Lunai Bioworks Inc. (NASDAQ:LNAI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 31 items for LNAI at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Lunai Bioworks Acquires CNS Patent Portfolio via $20M Preferred Stock Issuance, Bolstering Nasdaq Equity Compliance
- Lunai Bioworks Delays Key Shareholder Vote to Secure Quorum for Reverse Split
- Lunai Bioworks Postpones Special Meeting to Secure Quorum for Critical Reverse Stock Split Vote
- Lunai Bioworks Postpones Special Meeting to May 8th to Secure Reverse Stock Split Vote Amid Delisting Threat
- Lunai Bioworks Schedules Shareholder Vote on Second Reverse Stock Split to Avoid Nasdaq Delisting
Financial Snapshot
Fiscal year ended June 30, 2026
Revenue
$51.99K
Net Income
-$3.56M
Diluted EPS
-$1.06
Op. Cash Flow
-$5.29M
Free Cash Flow
-$5.29M
Operating Income
-$8.7M
Cash & Equivalents
$1.71M
Debt / Equity
0.00×
Net Margin
-68.52×
Shares Outstanding
4.62M sh
Source: 10-K · filed 2026-10-13 · accession 0001731122-26-001339
feed LNAI - Filings & News (Page 2)
LNAI
May 01, 2026, 5:17 PM EDT
LNAI
Apr 28, 2026, 5:33 PM EDT
LNAI
Apr 28, 2026, 5:30 PM EDT
LNAI
Apr 28, 2026, 5:00 PM EDT
LNAI
Apr 13, 2026, 5:15 PM EDT
LNAI
Apr 02, 2026, 5:01 PM EDT
LNAI
Mar 26, 2026, 8:52 AM EDT
LNAI
Mar 05, 2026, 4:46 PM EST
LNAI
Feb 23, 2026, 4:33 PM EST
LNAI
Feb 17, 2026, 3:16 PM EST
LNAI
Feb 12, 2026, 4:15 PM EST